After dealing with a deployment problem with glucose monitors earlier this year, interim CEO Jake Leach said improving ...
Medical device maker Dexcom topped Wall Street estimates for third-quarter results on Thursday, driven by robust demand for its continuous glucose monitoring systems.
However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...
Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of DexCom, Inc. (NASDAQ: DXCM) s ...
The use of CGM has been growing among people without diabetes, including those with prediabetes, particularly with the ...
Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.
Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...
AI is having a significant impact on the business world, affecting jobs, workers, firms, and industries Elysse Bell is a finance and business writer for Investopedia. She writes about small business, ...
Research shows that more daytime movement in pregnant women with hyperglycemia can raise nighttime blood sugar, highlighting ...
Dexcom’s G7 CGM [Image from Dexcom] A class action lawsuit has been filed against Dexcom (Nasdaq:DXCM) in the U.S. District Court for the Central District of California. The lawsuit, led by plaintiff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results